Novartis drug VotubiaR approved in the EU as first medication to treat ... Reuters Basel, November 5, 2012 - Novartis received approval from the European Commission (EC) for Votubia R (everolimus) tablets* for the treatment of adult patients with renal angiomyolipoma associated with tuberous sclerosis complex (TSC) who are at risk of ... Novartis gets another approval for everolimus in EU |
